{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T06:54:14Z","timestamp":1760079254516},"reference-count":24,"publisher":"Wiley","issue":"2","license":[{"start":{"date-parts":[[2006,7,18]],"date-time":"2006-07-18T00:00:00Z","timestamp":1153180800000},"content-version":"vor","delay-in-days":11476,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intl Journal of Cancer"],"published-print":{"date-parts":[[1975,2,15]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Growth of intrapleurally injected cells of immunogenic methylcholanthrene\u2010induced rat sarcomas was suppressed by intrapleural injection of viable or 1 \u00d7 10<jats:sup>6<\/jats:sup> R radiationsterilized BCG vaccine. As little as 10 \u03bcg moist weight of organisms was effective, and treatment could be given several days before or after tumour challenge. Pleural effusion growth of a moderately immunogenic ascitic hepatoma was also controlled by intrapleurally administered BCG. In contrast, BCG injected intravenously, subcutaneously or intraperitoneally was without influence on pleural tumour growths. Similarly, intraperitoneal growth of these tumours was suppressed only by intraperitoneal injection of BCG. With two other transplanted tumours, a chemically induced mammary carcinoma and a spontaneous sarcoma, both of which lack significant immunogenicity, BCG treatment of pleural and peritoneal growths was less successful and more variable. Nevertheless, these studies indicate the potential of this type of treatment of thoracic and peritoneal tumour deposits for possible clinical application in the treatment of malignant mesothelioma.<\/jats:p>","DOI":"10.1002\/ijc.2910150212","type":"journal-article","created":{"date-parts":[[2007,2,19]],"date-time":"2007-02-19T15:57:57Z","timestamp":1171900677000},"page":"260-269","source":"Crossref","is-referenced-by-count":22,"title":["Bcg therapy of pleural and peritoneal growth of transplanted rat tumours"],"prefix":"10.1002","volume":"15","author":[{"given":"M. V.","family":"Pimm","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R. W.","family":"Baldwin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2006,7,18]]},"reference":[{"key":"e_1_2_1_2_1","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.2910130602"},{"key":"e_1_2_1_3_1","first-page":"875","article-title":"Influence of BCG infection on growth of 3\u2010methylcholanthreneinduced rat sarcomas","volume":"16","author":"Baldwin R. W.","year":"1971","journal-title":"Europ. J. clin. biol. Res."},{"key":"e_1_2_1_4_1","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.1973.149"},{"key":"e_1_2_1_5_1","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.2910120213"},{"key":"e_1_2_1_6_1","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.1973.6"},{"key":"e_1_2_1_7_1","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.1974.223"},{"key":"e_1_2_1_8_1","first-page":"41","article-title":"The effect of living BCG on tumor growth in mice","volume":"12","author":"Bartlett G. L.","year":"1971","journal-title":"Proc. Amer. Ass. Cancer Res."},{"key":"e_1_2_1_9_1","first-page":"1709","article-title":"Tumor\u2010specific vaccine containing Mycobacterium bovis and tumor cells: safety and efficacy","volume":"48","author":"Bartlett G. L.","year":"1972","journal-title":"J. nat. Cancer Inst."},{"key":"e_1_2_1_10_1","first-page":"245","article-title":"Suppression of murine tumor growth by immune reaction to the Bacillus Calmette\u2010Gu\u00e9rin strain of Mycobacterium bovis","volume":"48","author":"Bartlett G. L.","year":"1972","journal-title":"J. nat. Cancer Inst."},{"key":"e_1_2_1_11_1","first-page":"987","article-title":"Effet de l'inoculation du bacille Calmette\u2010Gu\u00e9rin sur le d\u00e9veloppement de la tumeur ascitique d'Ehrlich chez la souris","volume":"153","author":"Biozzi G.","year":"1959","journal-title":"C. R. Soc. Biol. (Paris)"},{"key":"e_1_2_1_12_1","first-page":"213","article-title":"Immunotherapy of melanoma with intralesional BCG","volume":"39","author":"Bornstein R. S.","year":"1973","journal-title":"Nat. Cancer Inst. Monogr."},{"key":"e_1_2_1_13_1","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1093\/jnci\/51.1.241","article-title":"Tumor regression mediated by Mycobacterium bovix (strain BCG). Effects of isonicotinic acid hydrazide, cortisone acetate and antithymocyte serum","volume":"51","author":"Chung E. B.","year":"1973","journal-title":"J. nat. Cancer Inst."},{"key":"e_1_2_1_14_1","first-page":"277","volume-title":"Biological effects of asbestos","author":"Elmes P. C.","year":"1973"},{"key":"e_1_2_1_15_1","doi-asserted-by":"publisher","DOI":"10.1038\/236168a0"},{"key":"e_1_2_1_16_1","first-page":"1441","article-title":"Histopathology of tumor regression after intralesional injection of Mycobacterium bovis. I. Tumor growth and metastases","volume":"48","author":"Hanna M. G.","year":"1972","journal-title":"J. nat. Cancer Inst."},{"key":"e_1_2_1_17_1","first-page":"815","article-title":"N\u2010hydroxy\u20102\u2010acetylaminofluorene: a metabolite of 2\u2010acetylaminofluorene with increased carcinogenic activity in the rat","volume":"21","author":"Miller E. C.","year":"1961","journal-title":"Cancer Res."},{"key":"e_1_2_1_18_1","doi-asserted-by":"publisher","DOI":"10.1097\/00000658-197010000-00018"},{"key":"e_1_2_1_19_1","doi-asserted-by":"publisher","DOI":"10.1038\/184291a0"},{"key":"e_1_2_1_20_1","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.1974.162"},{"key":"e_1_2_1_21_1","first-page":"225","article-title":"Treatment of malignant melanoma by intratumoral injection of BCG","volume":"39","author":"Pinsky C. M.","year":"1973","journal-title":"Nat. Cancer Inst. Monogr."},{"key":"e_1_2_1_22_1","doi-asserted-by":"publisher","DOI":"10.1016\/0022-4804(72)90121-7"},{"key":"e_1_2_1_23_1","first-page":"433","article-title":"Suppression of tumor growth and induction of specific tumor immunity by intradermal inoculation of a mixture of living tumor cells and live Mycobacterium bovis in syngeneic mice","volume":"62","author":"Tanaka T.","year":"1971","journal-title":"Gann"},{"key":"e_1_2_1_24_1","first-page":"339","article-title":"Vaccination against tuberculosis with non\u2010living vaccine. III. Vaccination of guinea\u2010pigs with fractions of phenol\u2010killed tubercle bacilli","volume":"82","author":"Weiss D. W.","year":"1960","journal-title":"Amer. Rev. resp. Dis."},{"key":"e_1_2_1_25_1","first-page":"271","article-title":"Immunotherapy of cancer: regression of tumors after intralesional injection of living","volume":"172","author":"Zbar B.","year":"1971","journal-title":"Mycobacterium bovis. Science"}],"container-title":["International Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fijc.2910150212","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/ijc.2910150212","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,7]],"date-time":"2023-10-07T18:50:03Z","timestamp":1696704603000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/ijc.2910150212"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1975,2,15]]},"references-count":24,"journal-issue":{"issue":"2","published-print":{"date-parts":[[1975,2,15]]}},"alternative-id":["10.1002\/ijc.2910150212"],"URL":"https:\/\/doi.org\/10.1002\/ijc.2910150212","archive":["Portico"],"relation":{},"ISSN":["0020-7136","1097-0215"],"issn-type":[{"value":"0020-7136","type":"print"},{"value":"1097-0215","type":"electronic"}],"subject":[],"published":{"date-parts":[[1975,2,15]]}}}